Part III – HKEX: Listing biotech & mineral companies
This part will continue the discussion of the listing of pre-revenue biotech companies, which will subsequently go on to outline the listing document disclosure requirements and continuing obligations.
This part will conclude the series with a discussion of listing mineral companies under Ch.18 of the HKEx Listing Rules, outlining the eligibility requirements, disclosure requirements, continuing obligations and other important requirements and obligations.
We look forward to meeting you for Part III!
For more information please click here.
You can watch the webinar by following the link.